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ABSTRACT 
ellular signalling pathways are the master 
controls of the biology of the cell, which 
includes cell communication, growth, death, and 
differentiation. The activities of these signalling 
proteins directly influence gene function by 
regulation of the signalling pathways that mediate 
cellular responses. Recent advanced techniques 
have given rise to a number of emerging tools for 
the analysis of cellular signalling that profile the 
proteome or the protein complement of the 
genome. However, these tools for signal profiling 
still face significant challenges such as sensitivity, 
specificity and be a high throughput method before 
they are widely adopted. Sensitivity issues are 
paramount in detecting signalling proteins that are 
normally in low amounts. Conventional protein 
chip technology promises to be a powerful tool for 
large scale high-throughput proteome profiling but 
there are still significant drawbacks.  
Here we report the development and application of 
a novel multiplexed and high-throughput platform 
for the quantitative profiling of activated 
intracellular signalling proteins subsequent to 
ligand-receptor induced signalling. This spatially 
addressable biochip platform will allow 
comprehensive mapping of interconnected signal 
pathways, through identification of key functional 
signalling proteins (‘nodes’) in each pathway and 
quantifying their state of activity. 
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I. BACKGROUND 
Currently, proteome analysis faces a number of 
challenges which include specificity, sensitivity, 
quantifiability and the adaptability for high-
throughput studies. Though the current 
conventional method for global elucidation of 
protein expression patterns is two-dimensional gel 
electrophoresis, the procedure is laborious, 
expensive and has poor reproducibility. The 
detection thresholds of gel staining methods allows 
detection of only a fraction of the proteome pool 
and low abundance proteins are often masked by 
the presence of other proteins present in 
abundance. 2D gels and SELDI are complementary 
techniques as more than two dimensions are used 
to separate the proteins; however both are not apt 
for global protein profiling as mass spectrometry 
requires prior protein separation for low abundance 
proteins (1).  
While protein microarray technology has been 
successful in demonstrating its usefulness for large 
scale high-throughput proteome profiling (2-7), 
performance of antibody/antigen microarrays has 
been only moderately productive (1). 
Immobilization of either the capture antibodies or 
the protein samples on solid supports has 
drawbacks. Denaturation of the immobilized 
proteins as well as inconsistent orientation of 
antibodies/ligands on the arrays can lead to 
erroneous results (8-10). Recently, a new method 
adopting mass spectrometry techniques has been 
developed as an alternative to protein microarrays 
(11), but is time consuming and can be used only 
for a small set of proteins. 
Here we report a multiplexed, sensitive and 
high-throughput platform for the screening and 
quantification of intracellular signalling 
proteins from a complex mixture of proteins. 
Each signalling protein to be monitored has its 
capture moiety (specific antibody) linked to a 
specific oligo ‘tag’. The array involves the 
C 
oligonucleotide hybridization-directed (12, 13) 
localization and identification of different 
signalling proteins simultaneously in a rapid 
and easy manner.  
In order to accurately quantitate signalling events, 
the measurement platform should address three key 
issues: target specificity, target detection and high 
throughput multiplex detection of the analytes. 
Antibodies serve as powerful molecular 
recognition tools in addressing target specificity 
and hence will be used as the primary capture 
moiety. Fig. 1 below shows the schematics of the 
proposed antibody based capture moiety on to a 
spatially addressable array. The solid support for 
the immobilized oligonucleotide probes directly 
influences the detection limit of the array. An ideal 
surface has good spot homogeneity with increased 
sensitivity and good accessibility to the 
immobilized probes for hybridization (15). A high 
binding capacity can be achieved by adopting the 
pseudo-three dimensional dendrimeric linker 
system (14, 15) to provide a greater surface 
coverage of reactive sited for covalent probe 
immobilization.  
The proof of concept of this platform as a feasible 
signaling profiling tool has been reported in this 
paper. 
 
Fig. 1 Schematics of the ‘signalling chip’ platform 
 
II. MATERIALS AND METHODS 
A. Equipment. 
GenePix 4000B (Axon, CA) slide laser scanning 
system, Fluostar fluorescence spectrophotometer 
(BMG Technologies), MicroCasterTM Arrayer. 
B. Preparation of the glass slide with 
Immobilized Address (Tag-probe oligos). 
A reactive surface was created to enable covalent 
linking of the probe oligos on to a solid support, 
with high binding capacity. The preparation of the 
solid support involves the following steps: 
(a) Cleaning of glass slides 
(b) Reactive group functionalisation 
Glass slides containing immobilised 20bp poly A 
and poly T oligonucleotides were made using the 
MicroCaster Arrayer. This manual method of 
arraying produces array spots sizes of 
approximately 600 mm. 
C. Preparation of Antibody-oligo conjugates. 
The antibody-oligonucleotide conjugates were 
prepared by covalently linking them via  a 
crosslinker molecule. This hetero-functional 
crosslinker prevents homo-linkage of DNA and 
protein molecules. 
Monoclonal antibodies (p44/42 MAPK-IgG, Cell 
Signaling, NEB) were cross-linked to 20bp poly A 
oligonucleotides. The antibody was purified to 
remove excess crosslinker and unlinked 
Imaging 
Capture 
Cell lysate preparation 
Conjugate preparation 
Oligonucleotide design 
‘tag-probe’ 
microarray 
‘tag’ oligo 
oligonucleotides by filtration using membrane 
spin filters (Microcon). 
D. Preparation of labeled cell lysate . 
Protein extraction from cell culture. 
Neuro 2A cells transfected with GFR1a (gdnf 
family receptor 1a isoform) were grown overnight 
in DMEM with 10% FCS, 0.4mg/ml G418 
antibiotic . The cells were treated with DMEM 
containing 0.5% FCS before stimulation. 
The sorbitol treated (osmotically stressed) cells 
were lysed using a mild detergent lysis solution 
containing phosphatase inhibitors. The lysates 
were centrifuged at high speed (16,000 rcf) and 
the supernatant was collected. 
Labeling of proteins extracted. 
The cell lysates were labeled with Cy3 or Cy5 
fluorescent mono-reactive dyes (Amersham 
Biosciences) in 0.1M sodium bicarbonate buffer. 
Unbound dye was removed from the labelled cell 
lysates using protein desalting columns (Pierce). 
E. Screening protein profiles on the tag-probe 
array. 
The prepared tag-probe oligo arrays were 
preblocked to prevent non-specific binding of the 
labeled cell lysate to the array surface. The 
antibody conjugate incubated with the labeled cell 
lysate was allowed to hybridize on the slide in 
1×PBS 0.1%TX for 60 min and then washed with 
1×PBS 0.1%TX. The hybridized slides were then 
scanned using the Genepix 4000B (Axon, CA) 
laser scanner. 
III. RESULTS AND DISCUSSION 
A. Immobilization of probes on slides 
Prepared glass slides were covalently linked to bi-
functional Cy3-amino modified 20bp 
oligonucleotides (in 1X PBS). 
A high density of immobilized probes on the glass 
surface improves the sensitivity of the arrayed 
spot. The binding capacity of the glass surface to 
probes was determined using bi-functional NH2- 
Cy3 polyT (20bp) oligonucleotides (Proligo) at 
different reaction concentrations (Fig. 2). A 
minimum concentration of 50 ? M of 
oligonucleotides was sufficient to achieve 
maximal probe density.  
B. DNA hybridisation using complimentary 
oligonucleotides to immobilised probes. 
The activities of the immobilized oligonucleotides 
(Cy3) were measured by hybridising with labeled 
complementary oligonucleotides (Cy5) (Fig. 3). 
The resultant yellow colored spot (Fig. 3(b)) 
indicates the presence of red (Cy5) and green 
(Cy3) labeled hybridized oligonucleotides. 
Non specific interaction with non complementary 
immobilised probes was similar to background. 
Furthermore, increasing the density of the 
immobilised probes did not impair 
oligonucleotide activities due to steric hindrance.  
 
Fig. 2 Binding capacity of the activated support 
was determined by spotting different 
concentrations of 5’NH2-polyT (20bp) Cy3-3’ 
using the MicroCasterTM Arrayer 
 
 (a) (b) 
Fig. 3 (a) Fluorescence scanning for the 
immobilized oligonucleotides on the activated 
support (b) Detection of Cy5-complementary 
oligonucleotides hybridized to immobilised 
oligonucleotides on the same slide.  
(a)&(b) spotted NH2 polyA (20bp) did not 
hybridize with the Cy5-polyA(20bp) oligos 
indicating low non-specific hybridization. 
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C. Antibody-oligonucleotide conjugates 
preparation. 
Crosslinked antibody-oligonucleotide conjugates 
were prepared using TRITC labeled antibodies 
and FAM labeled oligonucleotide, to monitor the 
formation of covalently linked conjugate moieties 
(Fig. 4). 
The results indicates the formation of the capture 
moiety consisting of oligonucleotides covalently 
linked to the antibody via the bifunctional cross 
linker (no cross linker was used for the negative 
control). 
 
Fig. 4 Antibody-oligonucleotide conjugate 
formation (capture moiety) was measured by 
monitoring fluorescence intensities of the TRITC 
Ab and FAM polyA (20bp). 
 
D. Protein capture on the tag-probe array 
Monoclonal antibodies (Phospho p44/42 MAPK-
IgG, Cell Sigaling, Beverly) conjugated to polyA 
(20bp) oligonucleotides were incubated with Cy3-
labeled sorbitol-treated cell lysate. The mixture 
was then allowed to hybridize to the probe array.  
Labelled antigen is detected by scanning on the 
Genepix 4000B laser scanner. Antigen captured 
by the capture moiety (activated MAPK protein)  
is indicated by a signal at the target probe spot 
(Fig. 5a). 
Spots with non complementary sequences to the 
capture moiety showed signals similar to 
background (Fig. 5a). Cell lysate proteins did not 
bind significantly to unspotted areas of the glass 
slide. 
Unstimulated cells similarly assayed resulted in 
intermediate signals indicating elevated functional 
protein levels upon stimulation (Fig. 5b).  
 
 NH2-polyT(20bp)  NH2-polyA(20bp) 
a PhosphoMAPK Ab-polyA(20bp) conj + Cy3 cell 
lysate was  hybridized onto a slide spotted with 
NH2-polyT(20bp) and NH2-polyA(20bp) (non-
specific hybridization control) 
 
b Fluorescence intensity corresponding to the 
probe spots was measured using the Genepix 
4000B laser scanner (PMT 400). Relative protein 
levels with/without sorbitol stimulation of cells 
were detected. 
Fig. 5 Protein capture on the tag-probe array 
 
IV.  CONCLUSION 
The platform for protein profiling shown here 
demonstrates a viable alternative to conventional 
proteomic tools. The platform is much more rapid 
than Western blot analysis, the yardstick of 
protein analysis. It has good specificicity with 
high signal to noise ratios even in the absence of 
signal amplification as seen in ELISA assays. The 
microarray format of the platform promises 
multiplex capabilities and hence high throughput 
analysis. 
Over the past few years there has been 
tremendous progress in proteomic profiling 
technology. In an effort to understand the basic 
events that control complex biological processes, 
the demand for sensitive miniaturized high-
throughput proteomic tools is growing rapidly.  
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The technology used in the signalling chip 
described here can be adapted for high throughput 
screening of protein-protein interactions, protein 
enzymatic activities, drug discovery as well as 
clinical diagnostics. Rapid, easy analysis, sample 
volume economy, and multiplexed high-
throughput capability with automation feasibility 
are the highlights of this method. However there 
are some limitations. Highly specific antibodies 
have to be chosen. Oligonucleotide tags for the 
capture moieties should be designed such that 
there is no cross homology among the tags. 
Increased sensitivity and dynamic range of this 
technique may be achievable with various other 
detection methods such as RCA and label-free 
methods. 
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